Micro Emerging Active

RTW Investments bets on Apellis Pharmaceuticals

Score
0.3
Velocity
▲ 0.0
Articles
1
Sources
1

Summary

An article belongs to this narrative if it discusses RTW Investments' new position in Apellis Pharmaceuticals.

Related Articles

This New $193 Million Bet Targets a Biotech With $689 Million in Revenue and a …

Nasdaq · Mar 22, 2026
Bearish

Sources

This New $193 Million Bet Targets a Biotech With $689 … Nasdaq

Timeline

Last Updated Mar 22, 2026